Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
about
Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinideEvaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbitsFixed combination of repaglinide and metformin in the management of type 2 diabetes.Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.Modulation of nitrosative/oxidative stress in the lung of hyperglycemic rabbits by two antidiabetics, pioglitazone and repaglinide.Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide.
P2860
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
@ast
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
@en
type
label
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
@ast
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
@en
prefLabel
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
@ast
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
@en
P1476
Repaglinide--a new compound for the treatment of patients with type 2 diabetes
@en
P2093
B H Wolffenbuttel
P304
P356
10.1016/S0300-2977(99)00068-6
P577
1999-11-01T00:00:00Z